Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions

This publication has 25 references indexed in Scilit:

• THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
  Annual Review of Medicine, 1997
• Docetaxel
  Drugs, 1996
• Docetaxel in stage III and IV non-small cell lung cancer
  European Journal Of Cancer, 1995
• Current status of Taxotere® (docetaxel) as a new treatment in breast cancer
  Breast Cancer Research and Treatment, 1995
• Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)
  British Journal of Cancer, 1994
• Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
  Journal of Clinical Oncology, 1994
• Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells
  Anti-Cancer Drugs, 1992
• Mechanism of action of taxol
  Trends in Pharmacological Sciences, 1992
• Relationships between the structure of taxol analogs and their antimitotic activity
  Journal of Medicinal Chemistry, 1991
• Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
  JNCI Journal of the National Cancer Institute, 1991